Steven Gullans
2017
In 2017, Steven Gullans earned a total compensation of $407.2K as Interim President and Chief Executive Officer at NeuroBo Pharmaceuticals, a 1% increase compared to previous year.
Compensation breakdown
| Option Awards | $353,264 |
|---|---|
| Salary | $30,376 |
| Other | $23,575 |
| Total | $407,215 |
Gullans received $353.3K in option awards, accounting for 87% of the total pay in 2017.
Gullans also received $30.4K in salary and $23.6K in other compensation.
Rankings
In 2017, Steven Gullans' compensation ranked 12,559th out of 14,666 executives tracked by ExecPay. In other words, Gullans earned more than 14.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,559 out of 14,666 | 14th |
Division Manufacturing | 4,944 out of 5,772 | 14th |
Major group Chemicals And Allied Products | 1,810 out of 2,075 | 13th |
Industry group Drugs | 1,507 out of 1,731 | 13th |
Industry Pharmaceutical Preparations | 1,166 out of 1,333 | 13th |
Source: SEC filing on April 17, 2018.
Gullans' colleagues
We found three more compensation records of executives who worked with Steven Gullans at NeuroBo Pharmaceuticals in 2017.